Chong Kun Dang boosts Q3 operating profit 15% on big pharma products
Predicted impact: Low
Q3 operating profit up 15.4%, a modest gain already reported; lowered one level.
Comments
No comments yet. Start the conversation.
Comments are people's own views. Nothing here is financial advice.